[EXCLUSIVE] Lobbying Disclosures in the US: How Big Pharma Fought the TRIPS Waiver & is Pushing for Strong Intellectual Property Protection in the Pandemic Agreement

Newsletter Edition #234 [The Files In-Depth]

Hi,

If you have trouble understanding why international diplomacy is a vastly unequal field, or in mapping the scale of corporate power in determining public health outcomes, read our edition today.

We bring you an exclusive investigation conducted by Public Citizen, an American nonprofit consumer advocacy organization, that has examined lobbying disclo…